Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes—Randomized controlled study—

Controlled Study ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl peptidase-4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12-week, open label, randomized controlled study in Japan (PREFERENCE 4 study)

Journal of Diabetes Investigation ◽

10.1111/jdi.12659 ◽

2017 ◽

Vol 9 (1) ◽

pp. 137-145 ◽

Cited By ~ 5

Author(s):

Hitoshi Ishii ◽

Yasuaki Hayashino ◽

Yasuhiro Akai ◽

Matahiro Yabuta ◽

Satoru Tsujii

Keyword(s):

Treatment Satisfaction ◽

Dipeptidyl Peptidase ◽

Hypoglycemic Agents ◽

Controlled Study ◽

Oral Hypoglycemic Agents ◽

Open Label ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01380.x ◽

2011 ◽

Vol 13 (7) ◽

pp. 594-603 ◽

Cited By ~ 68

Author(s):

K. Esposito ◽

D. Cozzolino ◽

G. Bellastella ◽

M. I. Maiorino ◽

P. Chiodini ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Hba1c Target

Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

10.37766/inplasy2021.12.0113 ◽

2021 ◽

Author(s):

Shangyu Chai ◽

◽

Ruya Zhang ◽

Ye Zhang ◽

Richard David Carr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Glycemic Variability ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Comparing the Effects of Ipragliflozin and Metformin on Visceral Fat Reduction in Patients with Type 2 Diabetes Inadequately Controlled with Sitagliptin–A Prospective, Multicenter, Blinded-Endpoint, Randomized Controlled Study in Japan (PRIME-V Study)

Diabetes ◽

10.2337/db18-257-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 257-OR

Author(s):

MASAYA KOSHIZAKA ◽

KO ISHIKAWA ◽

RYOICHI ISHIBASHI ◽

YOSHIRO MAEZAWA ◽

KENICHI SAKAMOTO ◽

...

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Controlled Study ◽

Randomized Controlled ◽

Fat Reduction

29-LB: A Multicenter, Randomized Controlled Study of the Efficacy of Once-Weekly DPP-4 Inhibitor Omarigliptin in Patients with Type 2 Diabetes Undergoing Maintenance Hemodialysis

Diabetes ◽

10.2337/db19-29-lb ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 29-LB

Author(s):

YUTA YOSHIZAWA ◽

MICHIHIRO HOSOJIMA ◽

HIDEYUKI KABASAWA ◽

NAOHITO TANABE ◽

TADAHIRO KITAMURA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Study ◽

Maintenance Hemodialysis ◽

Randomized Controlled

2209-PUB: Factors Associated with Switching from Sulfonylureas (SUs) to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) among Individuals with Type 2 Diabetes in the United States

Diabetes ◽

10.2337/db20-2209-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2209-PUB

Author(s):

XI TAN ◽

LINGFENG YANG ◽

KAMLESH KHUNTI ◽

RUYA ZHANG ◽

DIANA ZHANG ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Factors Associated ◽

Faculty Opinions recommendation of A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727146123.793527044 ◽

2017 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Diabetic Nephropathy ◽

Japanese Patients ◽

Controlled Study ◽

Randomized Controlled

Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors

Current Medicinal Chemistry ◽

10.2174/0929867322666150227153308 ◽

2015 ◽

Vol 22 (13) ◽

pp. 1573-1581 ◽

Cited By ~ 21

Author(s):

E. Matteucci ◽

O. Giampietro

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.205 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB47

Keyword(s):

Type 2 Diabetes ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Effectiveness of a Supportive Telephone Counseling Intervention in Type 2 Diabetes Patients: Randomized Controlled Study

PLoS ONE ◽

10.1371/journal.pone.0077954 ◽

2013 ◽

Vol 8 (10) ◽

pp. e77954 ◽

Cited By ~ 15

Author(s):

Ute Mons ◽

Elke Raum ◽

Heike U. Krämer ◽

Gernot Rüter ◽

Dietrich Rothenbacher ◽

...

Keyword(s):

Type 2 Diabetes ◽

Telephone Counseling ◽

Controlled Study ◽

Counseling Intervention ◽

Randomized Controlled ◽

Diabetes Patients